InvestorsObserver
×
News Home

Should You Buy GlycoMimetics Inc (GLYC) Stock Monday Morning?

Monday, November 21, 2022 06:48 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy GlycoMimetics Inc (GLYC) Stock Monday Morning?

GlycoMimetics Inc (GLYC) is lower by Monday morning, with the stock declining -6.67% in pre-market trading to 2.1. GLYC's short-term technical score of 98 indicates that the stock has traded more bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, GLYC ranks higher than 99% of stocks. GlycoMimetics Inc has risen 268.85% over the past month, closing at $0.62 on October 24. During this period of time, the stock fell as low as $0.62 and as high as $2.43. GLYC has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.

Overall Score - 90
GLYC has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on GLYC!
GlycoMimetics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 119 by this metric, GLYC ranks better than 119% of stocks.

Important Dates for Investors in GLYC:

-GlycoMimetics Inc is set to release earnings on 2/7/2023. Over the last 12 months, the company has reported EPS of $-1.02. -We do not have a set dividend date for GlycoMimetics Inc at this time. Click Here To Get The Full Report on GlycoMimetics Inc (GLYC)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App